Astec Lifesciences Rights Issue 2025 vs Kilitch Drugs (india) Rights Issue 2025

Comparison between Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025. Astec Lifesciences Rights Issue 2025 is listed on BSE, NSE while Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE.

 Astec Lifesciences LimitedKilitch Drugs (india) Ltd.
LogoAstec Lifesciences Rights Issue 2025 LogoKilitch Drugs (india) Rights Issue 2025 Logo
Listing AtBSE, NSEBSE, NSE
Terms of Payment

Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue.

The full amount of the Issue Price Rs 357/- will be payable on application.

Entitlement1 Rights Equity Share(s) for every 7 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Astec Lifesciences Rights Issue 2025 rights issue is ₹249.35 Crores, whereas Kilitch Drugs (india) Rights Issue 2025 rights issue size is ₹49.93 Crores.

 Astec Lifesciences LimitedKilitch Drugs (india) Ltd.
Issue Size28,01,673 shares13,98,463 shares
Issue Size (Amount)₹249.35 Crores₹49.93 Crores
Issue Price₹890 per share₹357 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Astec Lifesciences Rights Issue 2025 is Jul 04, 2025 while record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025.

 Astec Lifesciences LimitedKilitch Drugs (india) Ltd.
Record DateJul 04, 2025Jul 15, 2025
Credit of Rights EntitlementsJul 07, 2025Jul 16, 2025
Bid/Offer Opens OnJul 14, 2025Jul 23, 2025
Renunciation of Rights EntitlementsJul 22, 2025Aug 18, 2025
Bid/Offer Closes OnJul 28, 2025Aug 21, 2025
Deemed Date of AllotmentJul 29, 2025Aug 22, 2025
Credit DateJul 30, 2025Aug 26, 2025
Listing DateAug 01, 2025Aug 28, 2025

Financials details

Comparison of Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Astec Lifesciences LimitedKilitch Drugs (india) Ltd.
Financial

Astec Lifesciences Limited Financial Information (Restated Consolidated)

Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue381.30458.18
Profit After Tax-134.71-46.89
Net Worth234.75369.29
Reserves and Surplus215.13349.68
Amount in ₹ Crore

Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)

Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue198.32154.37
Profit After Tax24.9413.58
Net Worth202.33176.29
Reserves and Surplus186.25160.21
Amount in ₹ Crore

Compare with others

Compare:

Astec Lifesciences Rights Issue 2025 Vs Kilitch Drugs (india) Rights Issue 2025